FindTrial
Sign In

An observational study on the surveillance of sarcoma relapse based on personalized MRD detection

An observational study on the surveillance of sarcoma relapse based on personalized MRD detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083045
Enrollment
Unknown
Registered
2024-04-15
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoma

Interventions

MRD detection:None

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed as sarcoma; (2) No previous history of cancer; (3) In good general condition; (4) Patients who plan to undergo surgical treatment; (5) WES testing of primary tumors has been performed or WES testing is planned; (6) Clearly understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Subject’s previous history of cancer/secondary and recurrent tumors; (2) Do not agree to undergo blood collection or related genetic testing; (3) Other situations that are not suitable for inclusion as assessed by the researcher.

Design outcomes

Primary

MeasureTime frame
Disease-free survival;—

Secondary

MeasureTime frame
Overall survival;PR/CR;—

Countries

China

Contacts

Public ContactJunqiang Yin

The First Affiliated Hospital of Sun Yat-sen University

yinjunqiang77@163.com+86 20 8775 5766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 29, 2026